Skip to main content
NewslettersWatchlist

Kronos Bio Inc(KRON-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Kronos Bio Inc

1300 S. EL CAMINO REAL SUITE 400
SAN MATEO CA 94402 USA
P: 650-781-5200
http://www.kronosbio.com

Sectors & Indices

Sector
Industry
Employees

Profile

Kronos Bio Inc. is a clinical-stage biopharmaceutical company. It engages in discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio Inc. is headquartered in San Mateo, Calif.

Key Executives

NameTitle
Elizabeth A. OlekSenior VP, Divisional
Norbert W. BischofbergerCEO/Director/President
Sandra GardinerCFO/Chief Accounting Officer
Allison FrisbeeSenior VP, Divisional
Charles Y. LinSenior VP, Divisional

More from The Globe

Dividend investing has lost its mojo. Here’s why – and how to adapt
Ian McGugan
The Globe Investing Club 2024: Let the competition begin!
opinion
Here’s the real reason your Canadian stocks can’t keep up
Tim Shufelt
Dow ends above 40,000 milestone, TSX also at fresh record high
Traders work on the floor of the New York Stock Exchange (NYSE) on May 16.
number cruncher
U.S technology stocks with earnings and price momentum
For Number Cruncher column in Globe Investor/ROB only.
Lightspeed Commerce stock soars on better-than-expected profit forecast
Lightspeed Commerce Inc. CEO Dax Dasilva poses in the company's offices in Montreal, Wednesday, May 8, 2024. THE CANADIAN PRESS/Christinne Muschi
GameStop, AMC dive further as meme stocks rally tapers off
A screen displays the trading information for GameStop and AMC Theatres on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 15.
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.